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ABSTRACT
Complementary and alternative medicine (CAM) is becoming increasingly prevalent in
the United States, with notable usage of supplements, deep breathing exercises, and chiropractic
care. Despite this influx of CAM, nearly half of patients do not report their CAM use to their
medical provider (Jou & Johnson, 2016). Disclosing these practices to a medical provider is
pertinent to patient safety, as a number of potential drug interactions and side effects are
associated with different CAM practices. Current literature illustrates specific provider attributes
help facilitate an open dialogue with patients, or more specifically, a positive patient-provider
relationship. This research study examines if a correlation exists between provider characteristics
and patient disclosure of CAM use. Information was gathered via survey, and quantitative data
were statistically analyzed using the Likert scale. Based on the results, all patients in the survey
highly valued the following characteristics in their medical provider: a provider’s expanse of
medical knowledge, proficient communication skills, being incorporated into the medical
decision-making process, empathy, and amount of time spent during the visit. However, no
statistically significant difference exists between disclosure and non-disclosure groups for any of
the preceding provider attributes listed. Additionally, a provider’s relationship with their patient
did not appear to increase the likelihood of patient disclosure regarding CAM use.
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Chapter 1: Introduction
Introduction
Every patient deserves the utmost care. Some patients opt to see their medical provider
on a routine basis. Other patients may fear the thought of a clinic or hospital or have a general
mistrust of people in white coats, leading them to seek alternative remedies for their health.
Currently, one-third of adults utilize complementary and alternative medicine (CAM) in the
United States (Barnes, Bloom, & Nahin, 2008). As more patients follow this trend, the need for
disclosure between patients and their medical providers is increasingly vital. A provider’s ability
to facilitate an open dialogue will inevitably increase a patient’s satisfaction and compliance
(Peterson et al., 2016). This chapter will introduce complementary and alternative medicine, the
problem statement, the purpose of the study, the significance of the problem, research questions
posed, limitations to the study, definitions of terms, and ultimately, CAM disclosure’s potential
impact on the patient-provider relationship.
Background of the Problem
Complementary and alternative medicine has roots dating back to approximately 3,000
BC, and the practice was first documented in the United States beginning in the early 19th
century (Ehrlich, 2015).
The NCCAM [National Center for Complementary and Alternative Medicine] defines
CAM as “a group of diverse medical and health care systems, practices, and products that are not
presently considered to be part of conventional medicine.” NCCAM further classifies CAM
therapies into five distinct categories:
● alternative whole medical systems (homeopathic and naturopathic medicine,
Chinese medicine, and Ayurveda)
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● mind-body interventions (meditation, prayer, mental healing, art, music, and
dance therapy)
● biologically based therapies (herbs, foods, vitamins, and other dietary
supplements, including natural products such as shark cartilage)
● manipulative and body-based methods (chiropractic and osteopathic
manipulation, massage)
● energy therapies (qi gong, Reiki, therapeutic touch, or electromagnetic exposures)
(Ventola, 2010, p. 515).
The CAM industry presents a significant financial cost to the patient. In 2007 alone,
approximately 354 million visits to CAM practitioners were documented and an estimated 835
million CAM products were purchased (National Center for Complementary and Integrative
Health [NCCIH], 2017b). Nearly $34 billion is spent on CAM annually, accounting for 11.2% of
total out-of-pocket expenditures on health care in the United States (NCCIH, 2017b). Patient
disclosure of CAM usage to his or her provider is important because the provider can then
educate the patient on the known efficacy of CAM therapies. With this information, the patient
can make informed decisions and choose to spend their resources on therapies that are evidencebased, whether that is CAM or conventional medicine.
Numerous CAM therapies have significant drug interactions, potential detrimental side
effects, and/or may not contribute to the treatment of the disease, which adds to the importance
of full patient disclosure (Cohen, 2002). In the United States, drug regulations tend to emphasize
safety rather than efficacy with the primary goal of protecting consumers against fraud,
dangerous products, or practitioners (Bodeker and Burford, 2006). Many CAM therapies lack
governmental oversight, such as mind-body interventions, manipulations and body-based
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methods, and energy therapies. Unlike pharmaceuticals, which go through rigorous testing to
account for both safety and efficacy, supplements do not need to pass FDA approval to be
marketed in the United States (Ventola, 2010).
Despite lack of government control, many individuals consider CAM to be a safer
alternative to conventional medicine and perceive CAM as being “natural” (“Why People Use
Complementary or Alternative Therapies,” 2014). However, many toxicities have resulted from
combining certain CAM therapies with different medications (Cohen, 2002). A common
example of a negative drug interaction is St. John’s wort. This plant is commonly used as a CAM
treatment for depression, but St. John’s wort also appears to increase the risk of coagulopathies
in patients (Elmer, Lafferty, Tyree, & Lind, 2007). Other frequently utilized CAM products that
have been shown to have negative drug interactions include valerian and hawthorn. Medication
interactions may be synergistic or antagonistic with CAM, which makes patients’ disclosure of
CAM critical to prevent serious and possibly life-threatening interactions (Elmer et al, 2007).
Current research shows that nearly half of people who utilize CAM do not disclose their
use to medical providers during medical consultations (Jou & Johnson, 2016). A meta-analysis
also found that non-disclosure of CAM by patients was as high as 72% (Robinson & McGrail,
2004). The most common reasons why patients did not disclose CAM use to their providers was
because the patients were concerned that disclosure might negatively affect their relationship
with the provider, the provider did not ask, or the patient did not think the provider was
interested (Robison & McGrail, 2004).
Several other studies show that patients value medical care providers who convey
empathy, communicate effectively, and establish trust with their patients (Anderson, Barbara,
and Feldman, 2007). Patients may refrain from disclosing their CAM practices because their
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provider does not meet their expectations in these regards. Fostering an open relationship
between patients and providers is crucial for overall patient care. In one study, researchers from
Harvard Medical School randomly assigned patients with irritable bowel syndrome (IBS) to
acupuncture care with either minimal provider interactions or supportive provider interactions
(Conboy et al., 2010). The supportive interactions meant providers asked detailed questions, had
empathetic facial expressions, used active listening techniques, and expressed positive treatment
expectations (Conboy et al., 2010). Comparison of the two patient groups found significant
improvement in patients’ IBS symptoms when they received acupuncture with provider support
compared to acupuncture alone (Conboy et al., 2010). This study demonstrates the importance of
a supportive and positive patient-provider relationship. When the relationship improves, patient
health improves as well (Conboy et al., 2010).
Problem Statement
Despite the long-standing history of CAM, a large percentage of patients are not
disclosing CAM use to their conventional provider (Robinson & McGrail, 2004). Current
literature provides a limited understanding of how CAM disclosure can be encouraged by the
patient-provider relationship and/or provider characteristics.
Purpose of the Study
The purpose of this research study is to further understand the complex patient-provider
relationship specifically by assessing which attributes and characteristics a provider exhibit that
may facilitate a patient’s willingness to disclose the use of CAM. The information this study
gathers will allow medical providers to better serve their patients by learning how to
communicate with patients about CAM use and encourage CAM disclosure.
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Significance of the Problem
A disconnect often exists between patients and their providers, which can impede
communication between the two. Patients who do not feel comfortable communicating with their
provider may not be as open about their medical history, especially regarding their usage and
disclosure of CAM, limiting the quality of care being given to the patients. Current studies tend
to focus on why patients choose not to disclose their use of CAM and do not focus on what a
provider can do to encourage CAM disclosure. How providers engage their patients regarding
CAM use is essential because open dialogue can enable providers to gain a comprehensive
knowledge of their patients’ overall therapy modalities. This research will help providers
effectively treat patients through the integration of CAM and conventional medication.
Research Questions
The following research questions will be addressed:
● What attributes or characteristics do providers exhibit that help encourage a patient to
disclose their use of CAM?
● What is the correlation between CAM disclosure and positive patient-provider
relationships?
Limitations of the Study
As with any study, limitations exist. This study’s sample will be confined to survey
respondents at Life Preserver, a whole foods store in Brainerd, MN. This population is not
representative of the United States population as a whole in terms of ethnicity, income, sex, or
age. Additionally, the feedback from the survey will likely be subjective, due to the nature of the
questions asked. The study will interpret this feedback into quantitative data which will then be
statistically analyzed.
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Delimitations of the Study
In addition to limitations, there are also delimitations. Medical providers, such as
physicians, physician assistants, and nurse practitioners will not be surveyed, as the patient’s
perspective is the focus of this study. Only participants who have used CAM and have seen a
medical provider in the last 12 months will be assessed. Surveys will be conducted in a written
English format, and therefore, will exclude those who are non-English speaking or illiterate.
Moreover, responses will be measured using a Likert scale. The survey will give a precise
definition of what the study defines as CAM. However, participants will be unable to ask for
clarification.
Definitions of Terms
The following terms used in this research will be defined as:
● Complementary and alternative medicine: any non-mainstream medicine, which includes,
but is not limited to, vitamins and minerals not prescribed by a medical provider, herbs,
probiotics, mind-body therapies, traditional healers, ayurvedic medicine, traditional
medicine, homeopathy, and naturopathy.
● Medical provider: medically trained and licensed personnel including physicians,
physician assistants, and nurse practitioners.
● Conventional medicine: evidence-based medicine practiced by licensed physicians,
physician assistants, nurse practitioners, pharmacists, and therapists.
● Sample population: individuals surveyed who are residents of Minnesota, have seen a
medical provider within the last twelve months, and have utilized some form of CAM, as
defined above, in the last twelve months.
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● CAM disclosure: respondents who have utilized CAM and have also disclosed that usage
to their medical providers within the past year.
Conclusion
Despite the long-standing history of CAM, current literature has a limited understanding
of how CAM disclosure can be encouraged by the patient-provider relationship. The study is
attempting to further understand this complex relationship by specifically addressing CAM
disclosure and the patient’s perception of his or her provider. In Chapter 2, a literature review
encompassing discussion of the history of CAM, its prevalence in the United States, and CAM
regulation and safety will be thoroughly addressed. In addition, the study will examine
providers’ exhibited attributes that lead to patient satisfaction, as well as the traits that patients
seek out in providers. CAM disclosure and patient-provider relationships will also be addressed.
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Chapter 2: Literature Review
Introduction
This chapter reviews currently available literature and discusses the history of
complementary and alternative medicine, CAM prevalence in the United States, and the
regulation and safety of CAM. Furthermore, attributes that lead to patient satisfaction and factors
that determine which providers are sought out by patients will also be examined. Lastly, CAM
disclosure and the patient-provider relationship will be addressed.
Defining Complementary and Alternative Medicine
Complementary and alternative medicine encompasses a substantial collection of
healthcare treatment and practices. Complementary medicine is typically defined as nonmainstream practices that are used in conjunction with conventional medicine (NCCIH, 2006).
On the other hand, alternative medicine is non-mainstream practices that are utilized in place of
conventional medicine (NCCIH, 2006). The term CAM is an umbrella term used to describe both
types of non-mainstream practices. People rarely use only alternative medicine, as most use nonmainstream in conjunction with conventional treatments (NCCIH, 2006).
CAM is divided into two main classifications: natural products and mind-body practices
(NCCIH, 2006). Natural products, including herbs, vitamins, minerals, and probiotics, are sold
by many providers and retail stores as dietary supplements. Common herbs include acai, aloe
vera, cinnamon, cranberry, echinacea, garlic, ginger, green tea, essential oils, St. John’s wort,
and turmeric (NCCIH, 2006). Vitamins and minerals are organic substances that are needed in
small amounts for the normal functioning of the body (National Institute on Aging, 2017).
Probiotics are microorganisms which are ingested or applied to the skin with the intent of
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inducing health benefits (National Center for Complementary and Integrative Health [NCCIH],
2017a).
Mind and body practices are procedures or techniques which are administered by a
trained practitioner (NCCIH, 2006). These practices are utilized with the belief that the mind
plays an important role in the body’s physical health. The National Center for Complementary
and Integrative Health states that the most common types of mind and body practices include
deep breathing, yoga, tai chi, qi gong, chiropractic care, meditation, massage therapy,
progressive relaxation, and guided imagery (2006). Practices emphasize certain breathing
techniques, relaxation, concentration, body positions, and gentle movement (NCCIH, 2006).
Most CAM therapies fall into the categories of natural products or mind and body
practices (NCCIH, 2006). According to the National Center for Complementary and Integrative
Health (2006), all remaining CAM practices fall into a third miscellaneous category. This
category includes ayurvedic medicine, traditional Chinese medicine, homeopathy, and
naturopathy (NCCIH, 2006).
Ayurvedic medicine is a form of CAM which claims that each person has energies, called
doshas, which determine how the person should eat, exercise, and maintain a healthy lifestyle
(Freeman, 2003). Ayurvedic medicine attempts to prevent illness by balancing the body, mind,
and consciousness through the use of herbal remedies, yoga, meditation, diet, and lifestyle
(Freeman, 2003).
Traditional Chinese medicine (TCM) is based on the idea that there are opposing
energies, defined as yin and yang (Freeman, 2003). TCM practitioners also believe that in order
for patients to remain healthy, they must have a balanced and free-flowing qi, energy within
people (Freeman, 2003).
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Homeopathy is the belief in a law that states “like cures like,” meaning that a medicine
can cure a person with a certain illness if the same medicine would cause a similar illness in a
healthy person (National Center for Homeopathy, 2017). For example, small doses of an allergen
such as pollen can cause a person with seasonal allergies to become desensitized to the pollen.
Extremely small doses are given to patients and are claimed to be non-toxic and safe for
everyone including pregnant women, newborns, and children (National Center for Homeopathy,
2017).
Naturopathy is a combination of many of the above practices and also includes
manipulative therapy, acupuncture, prescription medication, natural childbirth, clinical and
diagnostic testing, and injection therapy (The American Association of Naturopathic Physicians,
2011). The American Association of Naturopathic Physicians (2011) states that naturopathic
medicine is based on the following principles: the healing power of nature, identifying and
treating the cause, doing no harm, the doctor as the teacher, treating the whole person, and
disease prevention.
Many healthcare facilities are bringing complementary and conventional medicine
together in an attempt to treat the whole patient (NCCIH, 2006). This type of healthcare is
known as integrative medicine. Integrative medicine is becoming increasingly common
throughout the United States, with research and usage being focused on pain management, relief
of symptoms in cancer patients, and promotion of healthy behaviors (NCCIH, 2006).
History of Complementary and Alternative Medicine
Herbal supplements have a steadfast history of use around the world (Ehrlich, 2015).
Documentation of using plants for medical purposes dates back to ancient Chinese and Egyptian
writings from around 3,000 BC (Ehrlich, 2015). African and Native American cultures utilized
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the benefits of herbs in healing rituals (Ehrlich, 2015). Interestingly, historians found that people
in different parts of the world were using similar plants for similar medical purposes (Ehrlich,
2015). Chinese medicine has one of the longest histories, originating 4,500 years ago (Wong &
Lien-teh, 1932). Although the time of conception of certain CAM therapies is unknown or
disputable, most forms of CAM have a longer history than that of conventional medicine
(Ehrlich, 2015).
Complementary and alternative medicine was introduced into the United States during
the late 19th century (Bassett, 2010). Scientists began to study plants and extract their active
ingredients which proved to be effective in treating certain diseases (Ehrlich, 2015). As
conventional medicine evolved and pharmaceutical drugs became more popular and effective,
the use of herbal medicines declined (Ehrlich, 2015). The growing popularity of conventional
medicine concerned certain individuals, leading to the formation of the Popular Health
Movement (PHM), a group of citizens worried about the potential dangers, cost, and supposed
ineffectiveness of conventional medicine (Freeman, 2003). This group successfully lobbied
states to allow for certain CAM therapies within the United States (Freeman, 2003).
Although scientific discoveries in the 19th century led to a major decline in the use of
herbal and other forms of alternative medicine, the use of CAM has had a resurgence in
popularity in the United States over the last 30 years (Bassett, 2010). Some feel that mainstream
medicine is associated with the potential to do more harm than good and therefore turn to CAM
(Emst, 2001). Because of the increase in CAM use, more and more medical schools are
incorporating CAM into their curricula (Ehrlich, 2015).
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Complementary and Alternative Medicine Prevalence in the United States
According to the 2007 National Health Interview Survey (NHIS), 38% of nearly 76,000
adults in the United States used some form of CAM within twelve months of the survey (Barnes
et al., 2008). Additionally, children with parents who used CAM were twice as likely to use
CAM themselves (Barnes et al., 2008). The largest percentage of CAM use in the U.S. are
nonvitamin, nonmineral, natural products (18%), deep breathing exercises (13%), chiropractic
care (9%), massage (8%), and yoga (6%). Of the natural products, the most commonly used in
order of prevalence were fish oil, glucosamine, echinacea, flaxseed oil, and ginseng (Barnes et
al., 2008).
The NHIS also found that CAM was most often used in adults to treat back, neck, or joint
pain, stiffness, arthritis, and musculoskeletal issues (Barnes et al., 2008). In the same survey,
CAM was found to be most often used in children for back or neck pain, head or chest colds,
anxiety, and attention-deficit/hyperactivity disorder (Barnes et al., 2008). Overall, the study
found that CAM is used more frequently among women ages 30-69, persons with higher
education and/or wealth, persons living in the Western United States, and former smokers.
Additionally, those with private health insurance were more likely to use mind-body therapies as
well as biologically based CAM therapies, than those with public health insurance or those who
are uninsured (Barnes et al., 2008).
Prevalence of CAM also appears to be related to sexual orientation and race. A study of
1,300 women found that homosexual women were more likely to use CAM compared to
heterosexual women (Smith et al., 2010). The study also found that the women who used CAM
tend to be Caucasian with higher education, reside in an urban area, and have a higher spirituality
rating (Smith et al., 2010).
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Complementary and Alternative Medicine Regulation and Safety
Only 25 of the 191 World Health Organization members have national policies regarding
CAM usage (World Health Organization, 2002). Research efforts regarding CAM have been
relatively limited in Western countries. The focus of most studies has been centered on either
herbal medicine, due to its potential for exploitation in drug discovery, or acupuncture, because
of its high-risk association with infection (Bodeker and Burford, 2006). CAM therapies, such as
mind-body interventions, manipulations and body-based methods, and energy therapies, are not
regulated by the U.S. government. Additionally, as opposed to pharmaceuticals that undergo
thorough testing to account for both safety and efficacy before being dispensed to the public,
supplements do not need to pass FDA approval to be sold in the United States (Ventola, 2010).
Many individuals who utilize complementary medicine are at risk for potential drug
interactions with conventional medicines (Cohen, 2002). One classic example is St. John’s wort,
used as an alternative for the treatment of depression (Cohen, 2002). St. John’s wort has been
shown to significantly lower the concentrations of concomitant drugs by inducing certain CYP
enzymes (Cohen, 2002). Valerian, thought to treat insomnia, has been linked to
pharmacodynamic effects on CNS depressants along with increasing drug concentrations of
alprazolam in individuals being treated for anxiety or panic disorders (Cohen, 2002). Hawthorn,
a plant used to remedy various cardiac diseases, has the potential to have additive vasodilation
effects, especially when paired with calcium channel blockers, nitrates, and phosphodiesterase
inhibitors (Cohen, 2002). The potential for cross-reactivity amongst CAM medicines and
traditional medicines is significantly high. These possible medication interactions underline the
importance of open dialogue between patients and their providers in the hopes of more patients
choosing to disclose their CAM use (Cohen, 2002).
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Patient Satisfaction and What They Seek Out in a Provider
Many factors contribute to the establishment of a positive patient-provider relationship
(Anderson et al., 2007). Similar to a consumerism-driven business model, patients can ultimately
dictate which providers they will seek out, follow-up with, and continue to see over the course of
their medical history (Stephens, 2010). Patient satisfaction surveys have become the gold
standard in regards to assessing the quality or perceived competency of providers. Based on
these reports, communication, trust, and empathy appear to be recurrent themes found to be most
valued by patients (Anderson et al., 2007).
Patients appreciate providers who take the time to listen, specifically drawing attention to
the patient’s concerns, and even engaging with the patient’s family members (Anderson et al.,
2007). Providers with strong interpersonal communication skills have the ability to establish a
sense of camaraderie, partnership, and trust with their patients by integrating the patients’
thoughts and opinions into the decision-making process (Anderson et al., 2007). Additionally, in
a medical setting, the vast majority of the information presented to patients by providers is often
technical and confusing. Patients admire providers who have the ability to propose complex
medical terminology in an understandable, condensed, and conversational style format
(Anderson et al., 2007). Moreover, patients value providers who have an open, nonjudgmental,
and empathetic viewpoint and who listen to the patient’s medical issues as well as their spiritual
troubles (Anderson et al., 2007).
A perceived lack of shared decision-making or low trust of the provider has been shown
to produce detrimental health effects, especially with regards to medication compliance (Bauer et
al., 2014). In a study of adults with diabetes, patients who perceived less involvement in
decision-making had doubled non-adherence rates compared to patients who felt they were fully
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participating in their health-related discussions (Bauer et al., 2014). Furthermore, consistency in
obtaining preventative cancer screenings was significantly impacted by the level of
communication between the patient and the medical provider (Peterson et al., 2016). A simple
recommendation by the provider was not enough; often a thorough discussion was required for
optimal patient compliance (Peterson et al., 2016). Specifically, one of the greatest indicators for
screening adherence was the amount of provider enthusiasm and encouragement perceived by
patients, in addition to addressing patient barriers and thoroughly explaining of screening
procedures (Peterson et al., 2016).
Disclosure of Complementary and Alternative Medicine and the Patient-Provider
Relationship
A national survey of the United States adult population found that nearly half of CAM
users did not disclose their CAM use to their medical provider (Jou & Johnson, 2016). This high
level of nondisclosure is extremely problematic because many alternative CAM therapies such as
vitamins, minerals, and herbal medicine can lead to reactions with conventional medications
(Elmer et al., 2007). For example, one study of CAM users in Australia found that patients were
at increased risk of blood coagulation when they combined garlic, ginkgo, ginseng, or St. John’s
wort with their prescribed warfarin (Elmer et al., 2007). When this information is not disclosed,
both the provider and the patient are unaware of how ineffective the warfarin will be, thereby
placing the patient in danger of clotting (Elmer et al., 2007).
The types of CAM patients use are important because different types have variable rates
of CAM disclosure. Patient disclosure of CAM is higher in CAM delivered by a professional,
such as chiropractic or acupuncture, compared to self-delivered CAM, such as vitamins and
herbal medicines (Chao, Wade, & Kronenberg, 2008). This study suggests that patients will
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disclose their professional-delivered CAM practices more often if the CAM practice is perceived
as legitimate, but self-delivered CAM may be more important to disclose due to possible
contraindications with conventional medications (Chao et al., 2008).
In order to better encourage CAM disclosure, understanding who is more likely to
divulge this information is imperative. One study found that Caucasian persons are more likely
to disclose CAM use compared to African-Americans, Latinos, and Asian Americans (Chao et
al., 2008). Interestingly, when the patients had a stronger relationship with their primary care
provider, the racial differences in CAM disclosure were no longer statistically significant (Chao
et al., 2008). CAM disclosure is also more likely amongst people who are married, reside in the
northeast of the US, have poor health, and/or are female (Chao et al., 2008).
Complementary and alternative medicine disclosure is vital for optimal patient care, but
disclosure is often hindered by a poor patient-provider relationship. Robinson and McGrail
(2004) reviewed 12 different studies evaluating non-disclosure of CAM and found the most
common reasons for not disclosing CAM use to medical providers is fear of negative responses
from their provider, patients did not believe their provider needed to know, and the provider did
not ask or seemed disinterested. This same review found non-disclosure rates between CAM
users as high as 72% (Robinson & McGrail, 2004). The authors suggest patients do not disclose
their CAM use because of previous bad experiences with providers or because they want a
higher sense of control of their health care (Robinson & McGrail, 2004). The more insight there
are about reasons for nondisclosure, the better providers can understand patient decision-making
and encourage the disclosure of CAM (Robinson & McGrail, 2004). For example, providers can
facilitate a discussion about CAM and encourage the patient that CAM is relevant information
about his or her healthcare (Robinson & McGrail, 2004).
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If patients have had negative experiences with their medical provider, they are also more
likely to seek alternative therapies (Mao et al., 2008). One study found that cancer survivors with
unmet needs, including emotional and physical, were 63% more likely to use CAM therapies
compared to survivors who did not report any unmet needs (Mao et al., 2008). Another study by
Thorburn, Faith, Keon, and Tippens (2013) found that patients who felt discriminated against by
their providers were more likely to use herbal CAM therapies than patients who did not feel
marginalized. These studies suggest if patients have a stronger relationship with their provider,
the following occurs: the patients’ needs are more often met, the patients feel more respected,
and the patients would seek less additional CAM or conventional treatment (Mao et al., 2008;
Thorburn et al., 2013).
According to the 2008 Health Information National Trends Survey, strong patientcentered communication resulted in less patient use of CAM therapies and a higher disclosure
rate of CAM use to providers. Patient-centered communication was defined as provider driven
communication, specifically, fostering relationships, responding to emotions, and enabling the
patient’s self-management (Faith, Thorburn, & Tippens, 2015). Additionally, patients who
experienced this patient-centered communication were less likely to avoid their providers (Faith
et al., 2015). This study further suggests the stronger the relationship is between patient and
provider, the less likely the patient will avoid visiting his or her provider and will more often
disclose CAM use (Faith et al., 2015).
Disclosure of CAM is not only positively correlated with patient-centered care but also
positive CAM outcomes (Sirois, 2014). In one study, patient disclosure of CAM was higher
when patients had positive health outcomes resulting from CAM and/or had higher patientcentered care, specifically personalized care from a primary care provider (Sirois, 2014).
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Another study consisting of HIV-infected women found that the more engaging a provider is, the
more likely the patient disclosed of her CAM use (Liu et al., 2009). Both studies further illustrate
that the quality of the patient-provider relationship has an effect on CAM disclosure.
While many factors such as race or type of CAM are associated with CAM disclosure,
the patient-provider relationship is important because this relationship is something providers
can change. Providers can modify how they interact with their patients and encourage a trusting
relationship. Therefore, there is a need for more research focusing on trust between a patient and
provider and how this relationship correlates with improving CAM disclosure.
Conclusion
Complementary and alternative medical practices have been utilized for centuries,
growing to encompass natural substances as well as mind and body maneuvers (Ehrlich, 2015).
CAM’s integration into the United States’ market has been of particular importance due to its
lack of regulation and potential for significant drug interactions and side effects (Ventola, 2010;
Cohen, 2002). These possible dangers highlight the need for patient disclosure of CAM use and
especially because only half of CAM users divulged their CAM usage to their providers (Jou &
Johnson, 2016). The aim of this research is ultimately to understand which attributes or
characteristics that a provider exhibit help encourages a patient to disclose their CAM use to that
provider. Current literature has emphasized that patients have a desire for a provider with strong
interpersonal communication skills who is trustworthy and empathetic (Anderson et al., 2007).
From the information gathered by this study, medical providers will be able to apply these
characteristics to their healthcare practice, thus facilitating open dialogue and a fully
encompassing approach to a patient’s overall health.
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In Chapter 3, the study will discuss the methodology. Information will be gathered via a
Likert survey and statistically analyzed. Study design, population, experimental procedures,
limitations and delimitations, and data collection, will be discussed in depth.
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Chapter 3: Methodology
Introduction
The purpose of this study is to determine if a correlation existed between the
characteristics of the medical provider-patient relationship and a patient’s willingness to disclose
their CAM usage.
This research study addressed the following research questions:
1. Which attributes or characteristics do providers exhibit that help encourage a
patient to disclose their use of CAM?
2. What is the correlation between CAM disclosure and positive patient-provider
relationships?
Moving forward, the information gathered from this study may allow medical providers
to better serve their patients by fostering enhanced communication. This chapter specifically
discusses study design, the sample population, the experimental procedure, and data collection,
as well as limitations and delimitations of the study.
Study Design
This study was a quantitative, observational study using case-control for ingroup
comparison between participants who disclosed their CAM use to their providers versus
participants who did not disclose CAM use. Data was collected using a survey that determines
participants who use CAM therapies and whether or not they have disclosed their CAM use to
their medical providers within the past 12 months; participants who do not meet these criteria
were excluded from statistical analysis. The questionnaire retrospectively assessed the CAM
users’ relationships with their medical providers via a series of questions using five-point Likert
scales. The quantitative values of the patient-provider relationship established by the survey were
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statistically compared between the two groups of CAM users to determine if and how patientprovider relationships are correlated with CAM disclosure to medical providers. Data from these
surveys were collected over a period of two weeks.
Population
The site chosen for this study was LifePreserver Natural Foods, located in the Brainerd
Lakes area at 14715 Edgewood Dr N, Baxter, MN. Many of the customers who frequently visit
the study site use different CAM therapies. LifePreserver Whole Foods is a small, family-owned
health food store that sells a wide variety of vitamins, minerals, herbs, and other supplements.
The store also sells specialty foods such as gluten-free, organic, and vegan options. Researchers
chose this location because an assumed high percentage of participants will meet the
qualifications for the survey (ie. are users of CAM and have seen a medical provider within the
past 12 months). Furthermore, the population site was chosen because a researcher had
connections to the owners of LifePreserver Natural Foods, who agreed to have their customers
surveyed (Appendix D). Brainerd and Baxter are two towns adjacently located in Northern
Minnesota. According to the 2018 United States Census Bureau, the population of Brainerd was
13,465 and Baxter was 8,314.
The following demographics of Brainerd were taken from the U.S. Census Bureau from
2013-2017 (U.S. Census Bureau, 2018):
1.) 92.0% of those over the age of 25 were high school graduates or higher and 19.7% had a
Bachelor’s degree or higher.
2.) The median household income was $34,358, and the poverty level was 16.4%.
3.) 10.3% of persons under the age of 65 years were without health insurance.
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Respondents of the survey that qualified for statistical analysis were men and women 18
years old or older and were able to read the survey, which was only provided in English. The
goal sample size for this survey was 30-50 participants.
Experimental Procedures
Permission was obtained from the owners of LifePreserver Natural Foods in Baxter,
Minnesota to utilize their customers as potential participants in the survey (Appendix D). Paper
copies of the survey were placed at the cashier counter for a period of two weeks in March of
2018, where LifePreserver staff requested customers to complete the survey. Names of the
participants or any other type of identifying information were not obtained to establish
participant confidentiality. Prior to asking any questions, the survey specifically informed the
participants of nondisclosure, the survey’s purpose, and any risks of the survey, as per IRB
approval (Appendix C). Participants were also informed directly from the paper surveys that they
were allowed to discontinue the survey at any time by discarding the survey and were
encouraged to contact researchers for any questions or concerns about the study.
Participants were allowed to complete the survey in store, and once completed,
participants were asked to return the survey to a locked box at the cashier counter that only the
researchers had access to. Researchers were not present at the time the participants had taken the
survey nor during survey submission.
After recording the data, the paper surveys were kept locked in Bethel University’s
Physician Assistant (PA) program office located at 2 Pine Tree Dr, Arden Hills, MN 55112, and
shredded after completion of data analysis. The electronic data, while being analyzed, was stored
on a password-protected computer owned by the researchers. After completion of the study, the
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data was kept on an external storage device locked in Bethel University’s PA program office for
a minimum of five years, per security requirements of the Bethel University’s PA program.
Data Analysis
The survey included questions about gender, age, and race, which was included purely
for demographic information about the sample population. Through a series of yes or no
questions, the sample population narrowed down participants to only those who have seen a
medical provider and who have used any form of CAM therapy, both within the past 12 months.
Next, participants were asked whether or not they have disclosed their use of a CAM therapy to
their medical provider, and these responses were organized using the coding system, 1 = yes and
2 = no. Finally, participants were asked 10 questions using Likert scales assessing the patientprovider relationship from the patient’s perspective of his or her provider (1 = completely
disagree to 5 = completely agree).
CAM disclosure (yes or no response) and each patient-provider attribute (answered using
a Likert scale) were analyzed for any correlation using a two-tailed t-test in Microsoft Excel on a
password protected computer. An analysis of variance (ANOVA) was used to compare the three
possible reasons for non-disclosure of CAM use to determine if the responses are statistically
different from one another; the ANOVA was also accomplished using Microsoft Excel. Post hoc
analysis using two-tailed t-tests was used for a positive ANOVA outcome to determine which
responses were statistically different.
This study was a correlational study including the following two variables: participants’
disclosure of CAM use to their medical provider within the past 12 months and the participants’
relationship with their medical provider measured by the following provider attributes: medical
knowledge, communication skills, ability to include the patient in the medical decision-making
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process, provider empathy, provider time spent with the patient, patient satisfaction with the
provider, and patient trust in the medical provider.
Reliability and Validity
The survey utilized was created by the researchers themselves for the specific purpose of
this study. The questionnaire was original and not borrowed from any other research, and each
question was created with the research questions in mind to establish the reliability of the survey.
Because of the novelty of this survey, validity and reliability were difficult to establish.
Therefore, both content validity and reliability of the survey were evaluated and enhanced by a
small review panel of five individuals similar to the expected survey population. The review
panel consisted of family and friends of the researchers who had a similar education level as the
predicted sample population, use some form of CAM, and were not students or educational
faculty of Bethel University.
Limitations
Within the experimental procedure, several limitations existed. This study’s sample was
confined to survey respondents at LifePreserver. This population is not representative of the
United States population as a whole in terms of ethnicity, income, sex, or age. Furthermore, the
researchers were relying on customer willingness to take the survey and honesty with their
answers. Additionally, the feedback from the survey was subjective, due to the nature of the
questions about attributes related to patient-provider relationships. The study interpreted this
feedback into quantitative data via Likert scale answers which were statistically analyzed.
Because the study was an observational study of two individual variables that were not
being directly affected by the study, researchers can only assess the correlation between the two
variables. No evidence for cause and effect was present and researchers were not able to
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determine if patient-provider relationships affected CAM disclosure, if CAM disclosure affected
the patient-provider relationship, or if a third unobserved variable had affected both CAM
disclosure and the patient-provider relationship.
Delimitations
In addition to limitations, delimitations were another component to consider. Medical
providers, such as physicians, physician assistants, and nurse practitioners, were not surveyed, as
the patient’s perspective was the focus of this study. Only participants who have used CAM and
have seen a medical provider in the last 12 months were surveyed. Surveys were conducted in a
written English format, and therefore, excluded those who are non-English speaking or illiterate.
Moreover, responses were measured using a Likert scale. The survey gave a precise definition of
what the study defined as CAM, however, participants were unable to ask for clarification.
Conclusion
In conclusion, a paper survey was distributed to LifePreserver customers in an attempt to
assess and understand which, if any, attributes of the medical provider-patient relationship were
correlated with patient disclosure of CAM. Chapter 4 presents the results of the statistical
analysis and cite any statistically significant relationships, and Chapter 5 summarizes the study’s
findings in relation to the researcher’s literature review. Researchers then make inferences about
possible causations for any observed correlations between patient-provider relationships and
CAM disclosure. Further limitations of the study are discussed in detail, and lastly, the potential
for further research in this area is examined.
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Chapter 4: Results
Introduction
This chapter will display and analyze the data collected from surveys completed by
customers at LifePreserver Natural Foods in Baxter, Minnesota. Strict standards were applied to
the participants in order to determine who qualified for the study. Demographics, including sex,
age, and ethnicity, were examined to provide a snapshot of the sample population. Types of
provider and disclosure rates were then reviewed. An open-ended question was used to
determine the different types of CAM utilized. Excel was used to analyze the results from the
study using two-tailed T-tests and a two-tailed ANOVA. In order for the data to be considered
statistically significant, a p-value of less than 0.05 was established. Figures and tables were
created using Excel and Lucidchart and are provided in the following sections to illustrate the
findings of the study.
Participants
There were a total of 36 participants in the study. In order to qualify, participants were
required to have seen a medical provider in the last 12 months and use at least one form of
complementary and alternative medicine within the last 12 months (Figure 1). Of the 36
participants surveyed, 5 were disqualified because they had not met the first criteria: having seen
a medical provider in the past 12 months (Figure 1). Every one of the remaining 31 participants
met the second criteria: having used CAM in the past 12 months (Figure 1). Of the 31
participants who qualified for the study, 25 disclosed their CAM use to their medical provider,
and the remaining 6 participants did not disclose their CAM use to their medical provider (Figure
1).
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Figure 1. Survey Outcomes During the Two-Week Study Period
Figure 1 illustrates the number of total participants who qualified for the survey (n=31)
and those who were disqualified for not seeking treatment from a medical provider in the
previous 12 months as well as used a form of CAM within the past 12 months (n=5).
Demographics
Demographics of survey respondents were collected regarding sex, age, and ethnicity.
Predetermined categories were available for selection. Sex included male, female, and other. Age
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was grouped into ages 18-25, 26-40, 41-59, and >60, with individuals under 18 disqualified from
participating. Each age group was then given a numerical value of 1, 2, 3, and 4, respectively to
determine the mean age range. Ethnicity options were White, African American, Hispanic,
Asian, and other. The preceding demographics were then grouped into “Yes” and “No”
respondents based on their CAM disclosure to their medical provider. All 31 participants were
asked, “Within the past 12 months, have you disclosed any of your CAM therapies to your
medical provider?” Both male and female participants had a higher rate of CAM disclosure
compared to non-disclosure of CAM, at 83.33% and 80.00% respectively (Table 1). The average
age of “Yes” respondents fell into the 41-59 age bracket, while the average age of “No”
respondents was in the 26-40 age group (Table 1). All valid participants in the survey selected
“white” for ethnicity.
Table 1
Demographics of Survey Participants
Demographic
CAM Disclosure
Non-disclosure
Total Participants (n)
Sex
Male
83.33%
16.67%
6
Female
80.00%
20.00%
25
a
Age
Numerical Mean
3.2 ± 1.00
2.0 ± 0.63
2.97 ± 1.05
Age Group Mean
41-59
26-40
41-59
Ethnicityb
White
81%
19%
31
Other
0%
0%
0
Note. All individuals who had qualified for and completed the survey were included in the
demographics.
aParticipants

were given the opportunity to select between age groups of 18-25, 26-40, 41-59,
and >60. Each group was then given a numerical value of 1, 2, 3, and 4, respectively, and then
numerical means were determined for disclosure versus non-disclosure. The numerical means
were then given their closet corresponding age group.
bSelection of ethnicity on the survey was divided into White, African American, Hispanic,
Asian, and other. All 31 respondents were white.
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Participants of the survey were allowed to select the type of provider they have sought
out within the past 12 months, with options of MD/DO, PA, and NP. Each survey taker was not
limited to one answer, hence why totals for each category exceed the number of participants.
Those that saw nurse practitioners had a disclosure rate of 100%, followed by physician
assistants at 87.50%. Medical doctors and doctor of osteopathic medicine had the lowest
disclosure rate at 77.78%.
Table 2
Type of Provider and Patient Disclosure Rates of CAM
Type of Provider
CAM Disclosure
Non-disclosure
Total Participants (n)
MD/DO
77.78%
22.22%
27
PA
87.50%
12.50%
8
NP
100%
0%
7
Note. Participants in the survey were allowed to select their current provider from predetermined categories of MD/DO, PA, and NP. Multiple selections were allowed, thus
accounting for the increased totals.
Participants were asked about their CAM use with an open-ended question and were
given the option to write in their individual type of CAM. This question was asked to ensure
participants understood what was referred to as “CAM”. No participants were disqualified for
their answers, as all of them used at least one form of CAM.
The most common form of CAM used by participants was vitamins (n=21), followed by
herbs (n=18), minerals (n=16), and probiotics (n=15). Other less common forms of CAM used
by participants include homeopathy (n=12), traditional medicine (n=4), massage (n=4),
chiropractor (n=4), functional medicine (n=3), naturopathy (n=2), plant-based medicine (n=1),
collagen (n=1), acupuncture (n=1), essential oils (n=1), fish oil (n=1), coQ10 (n=1), and
traditional healers (n=1). Many participants reported the use of multiple forms of CAM. Twenty-

39

five of the 31 participants who qualified reported using more than one form of CAM
simultaneously (Figure 2).

Naturopathy (1.9%) Other (6.6%)
Functional Medicine
(2.8%)

Vitamins (19.8%)

Traditional
Medicine (3.8%)
Massage (3.8%)
Chiropractor (3.8%)

Homeopathy
(11.3%)

Herbs (17.0%

Probiotics (14.2%)
Minerals (15.1%)

Figure 2. Types of CAM Used by Participants Within the Past 12 Months
Respondents were asked in the form of an open-ended question to list the type of CAM
they use. Figure 2 represents the percentage of participants that utilized each individual type of
CAM. The category “other” includes plant-based, collagen, acupuncture, essential oils, fish oil,
and CoQ10.
Data Analysis
Participants were asked to rate their provider’s attributes on a Likert scale of 1 to 5, with
1 as completely disagree and 5 as completely agree. These attributes included: a provider's
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medical knowledge, communication skills, medical decision-making (MDM) process, empathy,
and time spent during a visit.
A total of 31 participants were qualified to answer. Of the qualified participants, 29 of
the 31 answered the provider attribute questions. Of these 29 participants, 24 disclosed their
CAM use to their provider and 5 did not disclose their use. The mean scores were narrow
between all provider attribute categories, ranging from only 4.0 to 4.6. The means and standard
deviations of each group were then used in two-tailed t-tests to determine if there was a statistical
difference between responses. The analysis revealed no significant difference between disclosure
and non-disclosure of CAM use for any of the provider attributes. Table 3 shows the p-values
between disclosure and non-disclosure rates based on provider attributes, and Figure 3 illustrates
means and standard deviations for each provider attribute between disclosure and non-disclosure.
Table 3
Provider Attributes and Patient Disclosure Rates of CAM
Provider Attributes
CAM Disclosure (M ± SD) Non-disclosure (M ± SD) p-value
Medical Knowledge
4.0 ± 1.4 (n = 24)
4.2 ± 1.7 (n = 5)
0.76
Communication Skills
4.3 ± 0.8 (n = 24)
4.6 ± 0.3 (n = 5)
0.34
Medical Decision-Making
4.2 ± 1.4 (n = 24)
4.6 ± 0.8 (n = 5)
0.43
Empathy
4.0 ± 1.4 (n = 24)
4.4 ± 0.8 (n = 5)
0.47
Time Spent with Patient
4.1 ± 1.4 (n = 24)
4.4 ± 0.3 (n = 5)
0.44
Note. Five-point Likert scale responses were averaged for each provider attribute, and means
with standard deviations were calculated for “CAM Disclosure” versus “Non-disclosure.” Pvalues were included comparing the two disclosure participant groups for each provider
attributes.
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Figure 3. Provider Attributes versus CAM Disclosure Rates
Participants were then asked to rate their relationship with their provider via a Likert
scale of 1 to 5, with 1 as completely disagree and 5 as completely agree. This patient-provider
relationship was assessed by analyzing a rating of patient trust and satisfaction with his or her
provider.
A total of 31 participants were qualified to answer. Of these 31 participants, 25 disclosed
their CAM use to their provider and 6 did not disclose their use. Twenty-four of the disclosure
participants replied to the statement about provider trust, and all 25 replied to the statement
rating their satisfaction with their medical provider. Five of the non-disclosure participants
replied to the statement rating their trust in their provider, and four replied to the statement rating
satisfaction in their provider.
Both groups of participants that disclosed CAM use and those that did not, averaged a
high Likert scale, indicating both groups felt trust and satisfaction in their provider. The means
and standard deviations of each group were then used in two-tailed t-tests to determine if there
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was a statistical difference between responses. The analysis showed that there was no significant
difference between disclosure and non-disclosure of CAM use for either provider trust or patient
satisfaction. Table 4 shows the p-values between disclosure and non-disclosure rates based on
provider trust and patient satisfaction, and Figure 4 illustrates means and standard deviations for
provider trust and patient satisfaction between disclosure and non-disclosure.
Table 4
Patients’ Relationship with Providers and Patient Disclosure Rates of CAM
Patient-Provider Relationship
CAM Disclosure (M ± SD) Non-disclosure (M ± SD) p-value
Patient Trust in Provider
4.0 ± 1.6 (n = 24)
4.2 ± 0.7 (n = 5)
0.61
Patient Satisfaction
3.8 ± 1.7 (n = 25)
4.3 ± 0.9 (n = 4)
0.49
Note. Five-point Likert scale responses were averaged for patient trust and satisfaction, and means
with standard deviations were calculated for “CAM Disclosure” versus “Non-disclosure.” Pvalues were included comparing the two disclosure participant groups for both patient-provider
relationship characteristics.
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Figure 4. Patients’ Relationship with Providers versus CAM Disclosure Rates
The six participants that stated they did not disclose their CAM use to their medical
provider were asked to rate how well they agreed with three different possible reasons they did
not disclose. These reasons were the following: because the participants wanted to avoid a
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negative response from their medical provider, their medical provider did not ask, or because
they did not believe the use of CAM was important for their provider to know. Participants were
asked to rate each statement on a Likert scale from 1 (completely disagree) to 5 (completely
agree).
Table 5 includes the mean score and standard deviation for each response; only five of
the six qualifying participants answered these questions on the survey. In addressing the
statement concerning a negative response, participants were variable across the Likert scale with
a mean of 3.6 and a high standard deviation of 2.3. The participants mostly agreed with the
statement that the provider did not ask with a mean of 4.2 and a tighter standard deviation of 0.7.
Finally, participants disagreed with the statement that they did not think disclosure was important
with a mean value of 1.8 and a standard deviation of 1.2 (Table 5). The comparisons of each
mean with standard deviation can be seen in Figure 5.
The means and standard deviations were then used in a two-tailed ANOVA to see if there
were statistical differences between the responses. Because the ANOVA determined a significant
difference at P<0.05 [F(2,12) = 5.57, P = 0.019], post hoc analysis was completed using twotailed t-tests comparing each group. A statistical difference does exist between the statements
“provider did not ask” compared to “patient did not think important” (Table 5). Participants
strongly agreed with the statement “providers did not ask,” and they strongly disagreed with the
statement that participants did not disclose CAM because they “did not think CAM use was
important”. Participants had a wide variation in responses agreeing and disagreeing with the
statement “avoiding a negative response” from their provider.
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Table 5
Comparisons of Patients’ Reasons for Non-Disclosure of CAM
T-test Comparisons (p-values)
Patient’s Reasons for
Non-Disclosure of CAM
Fear of Negative
Provider Did
Total (n) Mean SD Provider Response
Not Ask
Fear of Negative
Provider Response
5
3.6
2.3
Provider Did Not Ask
5
4.2
0.7
0.47
Patient Did Not Think
Important to Disclose
5
1.8
1.2
0.19
0.02
Note. The three patient’ reasons for Non-Disclosure of CAM were individually compared using
two-tailed t-tests after obtaining a statistically significant two-tailed ANOVA of the three reasons
using p<0.05 [F(2,12) = 5.57, P = 0.019].
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Figure 5. Participants’ Reasons for Non-Disclosure
Conclusion
Participant disclosure of CAM use did not have a statistically significant correlation with
any of the five provider attributes (medical knowledge p=0.76, communication skills p=0.34,
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medical decision-making p=0.43, empathy p=0.47, and time spent with patient p=0.44).
Participant disclosure of CAM did not have a statistically significant relationship with provider
trust (p=0.61) or patient satisfaction (p=0.49). The participants who did not disclose their CAM
use to their medical providers were also asked to rate how well they agreed with the three
statements indicating possible reasons why. The only significant relationship was between the
statements “patient did not think CAM disclosure was important” versus “the provider did not
ask” (P = 0.02). This statistical difference exists because participants mostly agree with the
statement “provider did not ask” (Mean = 4.2) and disagree with the statement “the patient did
not think CAM disclosure was important (Mean = 1.8). The final chapter thoroughly discusses
the data, assesses the limitations of the study, and explores how any significant results obtained
from the study can be used in practice.
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Chapter 5: Discussion
Introduction
The final chapter of this paper will discuss a summary of the results, limitations, and
further research about CAM disclosure and the patient-provider relationship. Specifically,
researchers will relate findings discovered from the survey to current literature. Limiting factors,
such as population size, homogeneous demographics, and subjective nature of the survey, will
also be addressed. Lastly, researchers will explore options for continuing investigation in this
field.
Summary of Results
The purpose of this current study was to determine if certain attributes or characteristics
exhibited by providers led to a patient’s disclosure of their CAM use. Previous research has
shown that patients value providers who appear open, nonjudgmental, and empathetic (Anderson
et al., 2007). This current study agrees with the previous research as all patients highly valued
the following characteristics in their medical provider: a provider’s expanse of medical
knowledge, proficient communication skills, being incorporated into the medical decisionmaking process, empathy, and amount of time spent during the visit. However, no statistically
significant difference exists between disclosure and non-disclosure groups for any of the
preceding provider attributes listed.
Additionally, this current study sought to expose a possible correlation between CAM
disclosure and a positive patient-provider relationship. Bauer et al. determined that a perceived
lack of shared decision-making or low trust of the provider led to harmful health effects,
especially with regard to medication compliance (2014). A number of other previous studies
have also shown that strong patient-centered communication results in less patient use of CAM
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as well as a higher disclosure rate of CAM. In this current study, a “positive” patient-provider
relationship was determined by utilizing trust and satisfaction as the core qualities assessed on a
Likert scale. The majority of patients surveyed exhibited high Likert scale ratings, and thus,
seemed to have had a “positive” relationship with their medical providers, regardless if the
provider is an MD/DO, PA, or NP. This finding was apparent across both disclosure and nondisclosure groups. Therefore, a provider’s relationship with their patient did not appear to
increase the likelihood for one to open up regarding one’s CAM use.
Jou and Johnson (2016) found that nearly half of CAM users did not disclose their use to
their medical providers. Similarly, researchers in this current small study found that 25 of 31
(81%) participants disclosed CAM use to their medical provider. Chae et al. (2008) discussed
that Caucasians and women are more likely to disclose CAM use than other ethnicities and
genders. This current study also found that participants were 100% Caucasian and 81% female,
which may be a contributing factor to the high disclosure rate.
Robinson and McGrail (2004) reviewed 12 different studies and determined that the most
common reasons for not disclosing CAM use were fear of negative responses from their
provider, patients did not believe their provider needed to know, and that the provider did not ask
or seemed disinterested. Based on participant feedback within this current study, patients found
CAM disclosure to be an important component of patient-provider discourse, as many strongly
disagreed with the assumption that CAM use was unimportant. Moreover, the most agreed upon
statement for a reason of non-disclosure was that providers did not ask patients about their CAM
use. The results from this study suggest that the best way to encourage disclosure of CAM use is
to simply ask the patient directly about CAM. As many CAM therapies can interfere with
conventional medications, providers need to be aware of what therapies their patients may be
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using. Some providers may want to blame the patient for not disclosing certain important
information. However, providers must realize that patients might not disclose this information
simply because the provider did not ask about CAM. Although most research suggests that there
are many factors that contribute to patient disclosure of CAM, asking a patient directly appears
to be one of the most significant factors. This question is simple to incorporate into the patient
interview, or even in a written questionnaire before the patient sees the provider.
A previous study has shown that a large number of adults in the United States,
approximately 38%, use at least some form of CAM (Barnes et al., 2008). Researchers conducted
this current study in a natural food health store, where 100% of participants used at least one
form of CAM. This result was expected as researchers strived to locate a population that would
meet the inclusion criteria for the survey.
The most common forms of CAM according to Barnes et al. were nonvitamin,
nonmineral, natural products (18%), deep breathing exercises (13%), chiropractic care (9%),
massage (8%), and yoga (6%) (2008). The findings of this current study were relatively
consistent with previous findings. Of the qualifying participants, the most common forms of
CAM used were vitamins (20%), herbs (17%), minerals (15%), probiotics (14%), chiropractor
(4%) and massage (4%).
Limitations
The most significant limiting factor in the research is the population size. Of the 36
responses, only 31 qualified for the study, and of those that qualified, the majority had disclosed
their CAM use to their provider (25 participants said “yes” versus the 5 that said “no”
disclosure). Because of the small population size, researchers were unlikely to find any
statistically significant differences, even if differences exist. For example, the mean scores for
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CAM disclosure were higher than non-disclosure when comparing all medical provider
attributes. However, the small population size for each group created difficulty in finding a P
value less than 0.05.
Another limitation of this study is the homogenous demographics of the participants.
One-hundred percent of the population is of white ethnicity, and 80.6% are female. Overall, the
participants are representative of a small group of customers from LifePreserver located in
Brainerd, Minnesota. The statistics cannot be extrapolated to other populations as not every
CAM user shops at LifePreserver.
The survey is also limited by participants’ honesty and willingness to complete the
survey. The surveys are only valid if participants take time to fully think about each question.
Because the surveys were handed out at the cashier desk of LifePresrver, the participants could
have hastily answered questions and not give their most truthful response. In addition, multiple
participants did not complete their surveys fully and some completed sections of surveys they did
not qualify for. Only those that did not disclose CAM use to their provider were asked to rate
statements indicating possible reasons why; one person who did qualify did not answer. Finally,
two of the 31 qualified participants did not answer the last two questions, rating their medical
provider’s attributes and trust and satisfaction in their medical provider.
Further Research
Continuing this research would greatly benefit from a larger sample size. Larger sample
size could be accomplished by submitting surveys across multiple locations with possible CAM
users and for a longer duration of sample collection. Sites could include multiple whole foods
and supplement stores similar to LifePreserver, as well as medical clinics were participants
routinely seek treatment from physicians, physician assistants, and nurse practitioners. Multiple
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locations would also increase population diversity as more urban and rural locations could be
included. Researchers could also expand the diversity of the population by including surveys in
multiple written languages. Many CAM users are from diverse ethnic backgrounds and are
excluded from the study because all participants identified as white. Possible statistical
significance could be specific to certain ethnic backgrounds that are missed in this study.
Future research could also expand on understanding CAM disclosure from the
perspective of the medical provider. Physicians, physician assistants, and nurse practitioners
could be surveyed about their relationship with their patient and how this relationship affected
CAM disclosure. This insight could lead to understanding disclosure factors so that the patientprovider relationship can be improved upon from the provider’s perspective.
Another useful relationship that could be further developed is the type of provider versus
disclosure rates. In this study, nurse practitioners had 100% disclosure rate while physician
assistants and physicians had lower disclosure rates (Table 2). Although this correlation was not
statistically analyzed, a possible trend could exist between different types of providers resulting
in different provider-patient relationships.
Finally, researchers could create surveys that focus on specific types of CAM versus
CAM disclosure. The survey in this study could be problematic as CAM is extremely broad and
includes countless varieties. The survey could focus on a specific type of CAM, such as
chiropractic care, and determine individual disclosure rates and the patient-provider relationship.
A focused approach on each type of CAM could give a more detailed insight about compliance
with CAM disclosure.
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Conclusion
The purpose of this study was to determine if a relationship exists between patients’
disclosure of their complementary and alternative medicine versus the patients’ relationship with
their medical providers. The patient-provider relationship was determined by evaluating provider
attributes, how well the patient trusted his or her provider, and how satisfied the patient was with
his or her provider. The results of this study indicated no statistical significance existed between
disclosure and non-disclosure of CAM use versus patient-provider relationships. Participants
who did not disclose their CAM use to their medical provider mostly agreed with the statement
that the reason for non-disclosure was because their medical provider did not ask. Participants
disagreed with the statement that the reason for non-disclosure was because the participants did
not think CAM use was important. Further research could determine what affects CAM
disclosure by expanding the quantity and diversity of the research population, thus decreasing
limitations. Overall, this study aims to encourage better conversations between patients and their
providers, ultimately creating maximal health outcomes for patients; by integrating CAM therapy
into health care, providers will be able to create fulfilling relationships with their patients.
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APPENDIX A: QUESTIONNAIRE
Please circle your answers to the following questions.
1. Sex:
Male

Female

18-25

26-40

Other

2. Age:

3. Race/Ethnicity:
White

41-59

African American

Over 60

Hispanic

Asian

Other

4. Have you sought treatment from a medical provider in the last 12 months?
Medical provider: medically trained and licensed personnel in medicine including
physicians, physician assistants, and nurse practitioners.
Yes
No
If you answer “No” to question 4, you do not qualify for the survey. Please circle “No” and
then place the survey into the envelope. Thank you for your time.
5. What type of medical provider do you see for medical care?
Physician: MD or DO
Physician Assistant

Nurse Practitioner

6. Have you used any form of complementary and alternative medicine (CAM) or therapy in the
last 12 months?
Complementary and alternative medicine (CAM): vitamins, minerals, herbs, probiotics,
mind-body therapies, traditional healers, ayurvedic medicine, traditional medicine,
homeopathy, and naturopathy.
Yes, please list CAM use _____________________________________________
No
If you answer “No” to question 6, you do not qualify for the survey. Please circle “No” and
then place the survey into the envelope. Thank you for your time.
7. Within the past 12 months, have you disclosed any of your CAM therapies to your medical
provider?
Yes
No
If you answer “No” to this question, please continue to question 8. If you answer “Yes”,
please continue to question 9.
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8. Please indicate the extent to which you agree with the following statements about your
medical provider:
I do not disclose my CAM use because I want to avoid a negative response from my
provider.
(completely disagree) 1
2
3
4
5 (completely agree)
I do not disclose my CAM use because my provider did not ask about complementary
and alternative medicine use.
(completely disagree) 1
2
3
4
5 (completely agree)
I do not disclose my CAM use because I believe complementary and alternative medicine
use is not important for my provider to know.
(completely disagree) 1
2
3
4
5 (completely agree)
9. Please indicate the extent to which you agree with the following statements about your
medical provider:
My provider has a strong grasp of medical knowledge.
(completely disagree) 1
2
3
4
5 (completely agree)
My provider has strong communication skills.
(completely disagree) 1
2
3
4

5

(completely agree)

My provider includes me in the medical decision-making process.
(completely disagree) 1
2
3
4
5 (completely agree)
My provider demonstrates empathy with me.
(completely disagree) 1
2
3
4

5

(completely agree)

My provider spends an adequate amount of time with me.
(completely disagree) 1
2
3
4
5 (completely agree)
I trust my provider.
(completely disagree) 1

2

3

4

5

(completely agree)

10. Overall, how satisfied are you with your medical provider?
(completely unsatisfied) 1
2
3
4
5

(completely satisfied)
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APPENDIX B: INFORMED CONSENT FORM
Dear LifePreserver Natural Foods customer:
We are students from Bethel University conducting research as partial fulfillment of the
requirements for a Master's Degree in Physician Assistant Studies. The purpose of this research
study is to further understand the relationship between the patient and their provider by assessing
which attributes and characteristics a provider exhibit that may facilitate a patient’s willingness
to disclose the use of Complementary and Alternative Medicine (CAM). The information this
study gathers will allow medical providers to better serve their patients by learning how to
communicate with patients about CAM.
You were selected as a possible participant in this study because you are a customer of
LifePreserver Natural Foods, a store that celebrates the use of CAM. Participation in the survey
is completely voluntary. If you decide to take part in our research, your involvement includes
answering a questionnaire created by researchers from Bethel University’s PA program. The
survey will take approximately 5-10 minutes. Most participants will find the discussion
interesting and thought-provoking. Any information obtained in connection with this study is
confidential and will not be linked to the participants.
This research project has been reviewed and approved in accordance with Bethel University’s
Levels of Review for Research with Humans. If you have any questions about the research
and/or research participants’ rights or wish to report a research-related injury, please call Thomas
Stearns at 714-222-7207, Kathryn Ortmann at 715-933-0397, Norsha Scheil at 715-418-5259, or
Professor Cynthia Goetz, PA-C, at 651-638-6747. You will be offered a copy of this form to
keep.
We understand that you have a busy schedule and your time is limited. Please realize that your
participation is vital to the success of this research. The information that you provide is essential
to the validity of this study. Thank you in advance for your participation in this study.
Your consent is implied by the return of the completed questionnaire. You may obtain a copy of
this cover letter upon request. You are making a decision whether or not to participate. You may
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withdraw at any time without prejudice should you choose to discontinue participation in this
study.
Sincerely,
Thomas Stearns, Kathryn Ortmann, and Norsha Scheil
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APPENDIX C: BETHEL UNIVERSITY IRB APPROVAL
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APPENDIX D: POPULATION SITE APPROVAL

